These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30846101)

  • 1. von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.
    Van Belle E; Vincent F; Rauch A; Casari C; Jeanpierre E; Loobuyck V; Rosa M; Delhaye C; Spillemaeker H; Paris C; Debry N; Verdier B; Vincentelli A; Dupont A; Lenting PJ; Susen S
    J Am Coll Cardiol; 2019 Mar; 73(9):1078-1088. PubMed ID: 30846101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor revisited.
    Yasar SJ; Abdullah O; Fay W; Balla S
    J Interv Cardiol; 2018 Jun; 31(3):360-367. PubMed ID: 29285810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study).
    Blackshear JL; Wysokinska EM; Safford RE; Thomas CS; Stark ME; Shapiro BP; Ung S; Johns GS; Chen D
    Am J Cardiol; 2013 Feb; 111(3):374-81. PubMed ID: 23168287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
    Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
    Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
    Pawlitschek F; Keyl C; Zieger B; Budde U; Beyersdorf F; Neumann FJ; Stratz C; Nührenberg TG; Trenk D
    Thromb Haemost; 2018 Jan; 118(1):103-111. PubMed ID: 29304530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand Factor as a Novel Player in Valvular Heart Disease: From Bench to Valve Replacement.
    Gragnano F; Crisci M; Bigazzi MC; Bianchi R; Sperlongano S; Natale F; Fimiani F; Concilio C; Cesaro A; Pariggiano I; Diana V; Limongelli G; Cirillo P; Russo M; Golia E; Calabrò P
    Angiology; 2018 Feb; 69(2):103-112. PubMed ID: 28481153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
    Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
    Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Aortic Valve Stenosis.
    Frank RD; Lanzmich R; Haager PK; Budde U
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
    Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
    Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
    Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
    J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
    Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
    Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
    Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
    Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?
    Vincent F; Rauch A; Spillemaeker H; Vincentelli A; Paris C; Rosa M; Dupont A; Delhaye C; Verdier B; Robin E; Lenting PJ; Susen S; Van Belle E
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1775-1778. PubMed ID: 30190067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.
    Salaun E; Mahjoub H; Dahou A; Mathieu P; Larose É; Després JP; Rodés-Cabau J; Arsenault BJ; Puri R; Clavel MA; Pibarot P
    J Am Coll Cardiol; 2018 Jul; 72(3):241-251. PubMed ID: 30012316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.
    Spangenberg T; Budde U; Schewel D; Frerker C; Thielsen T; Kuck KH; Schäfer U
    JACC Cardiovasc Interv; 2015 Apr; 8(5):692-700. PubMed ID: 25946442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
    Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
    Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index.
    Tamura T; Horiuchi H; Imai M; Tada T; Shiomi H; Kuroda M; Nishimura S; Takahashi Y; Yoshikawa Y; Tsujimura A; Amano M; Hayama Y; Imamura S; Onishi N; Tamaki Y; Enomoto S; Miyake M; Kondo H; Kaitani K; Izumi C; Kimura T; Nakagawa Y
    J Atheroscler Thromb; 2015; 22(11):1115-23. PubMed ID: 26269004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
    Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era.
    Ibrahim H; Rondina MT; Kleiman NS
    Thromb Res; 2018 Oct; 170():20-27. PubMed ID: 30092557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.